tiprankstipranks
Advertisement
Advertisement

CHRO Stock Latest News

Roche announces launch of cobas eplex respiratory pathogen panel 3
The FlyRoche announces launch of cobas eplex respiratory pathogen panel 3
5d ago
CHRO
Cantor sees Scholar Rock dominating SMA market after Genentech news
PremiumThe Fly
Cantor sees Scholar Rock dominating SMA market after Genentech news
9d ago
CHRO
SRRK
Cantor sees Scholar Rock dominating SMA market after Genentech drops out
PremiumThe Fly
Cantor sees Scholar Rock dominating SMA market after Genentech drops out
9d ago
CHRO
SRRK
Trump Trade: President issues short-term waiver of Jones Act
PremiumThe Fly
Trump Trade: President issues short-term waiver of Jones Act
11d ago
AZN
BMY
Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
PremiumThe Fly
Trump claims TrumpRx website offers lowest prices, review says not so, NYT says
11d ago
AZN
BMY
Roche announces FDA categorized its Ionify steroid assays
PremiumThe FlyRoche announces FDA categorized its Ionify steroid assays
11d ago
CHRO
Olema Oncology price target lowered to $38 from $40 at Guggenheim
Premium
The Fly
Olema Oncology price target lowered to $38 from $40 at Guggenheim
12d ago
AZN
CHRO
Roche deploying more than 3,500 Nvidia Blackwell GPUs
Premium
The Fly
Roche deploying more than 3,500 Nvidia Blackwell GPUs
12d ago
CHRO
NVDA
Roche price target lowered to CHF 365 from CHF 385 at HSBC
PremiumThe Fly
Roche price target lowered to CHF 365 from CHF 385 at HSBC
12d ago
CHRO
Roche downgraded to Neutral from Outperform at BNP Paribas
PremiumThe Fly
Roche downgraded to Neutral from Outperform at BNP Paribas
12d ago
CHRO
District court rules federal limits to vaccines not based on science, NYT says
PremiumThe Fly
District court rules federal limits to vaccines not based on science, NYT says
12d ago
AZN
BMY
Piper Sandler biotech analysts hold analyst/industry conference call
PremiumThe Fly
Piper Sandler biotech analysts hold analyst/industry conference call
12d ago
CHRO
Roche receives CE Mark for Elecsys Apolipoprotein E4 test
PremiumThe FlyRoche receives CE Mark for Elecsys Apolipoprotein E4 test
13d ago
CHRO
Roche price target lowered to CHF 325 from CHF 350 at JPMorgan
Premium
The Fly
Roche price target lowered to CHF 325 from CHF 350 at JPMorgan
17d ago
CHRO
Xencor reports receipt of notice of termination of license agreement from Roche
Premium
The Fly
Xencor reports receipt of notice of termination of license agreement from Roche
19d ago
CHRO
XNCR
H.C. Wainwright does not see direct read from Roche miss to Olema’s OPERA-02
PremiumThe Fly
H.C. Wainwright does not see direct read from Roche miss to Olema’s OPERA-02
20d ago
CHRO
OLMA
Genentech announces persevERA Breast Cancer study did not meet primary endpoint
PremiumThe Fly
Genentech announces persevERA Breast Cancer study did not meet primary endpoint
20d ago
CHRO
Controversial Prasad leaving FDA, NYT reports
PremiumThe Fly
Controversial Prasad leaving FDA, NYT reports
20d ago
AZN
BMY
Roche Chairman says diagnostics division exposed to tariffs, Reuters says
PremiumThe Fly
Roche Chairman says diagnostics division exposed to tariffs, Reuters says
20d ago
CHRO
Genentech publishes ALLEGORY trial data in the New England Journal of Medicine
PremiumThe FlyGenentech publishes ALLEGORY trial data in the New England Journal of Medicine
23d ago
CHRO
Genentech reports Phase 2 ZUPREME-1 weight loss trial met primary endpoint
Premium
The Fly
Genentech reports Phase 2 ZUPREME-1 weight loss trial met primary endpoint
23d ago
CHRO
Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating
Premium
Ratings
Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating
27d ago
CHRO

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >